Study's Care of Acute Pancreatitis at Saint-Etienne University Hospital.

NCT ID: NCT06600828

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-06

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Internal medicine units treat patients with undifferentiated or multisystem diseases, with a non-specific organ approach.

In some cases, patients with single-organ disease may be admitted to internal medicine wards. Acute pancreatitis is the most common gastrointestinal illness requiring acute admission to hospital. It is characterised by local and systemic inflammation of the pancreas corresponding to single-organ disease.

For patients with single-organ disease such as acute pancreatitis, it is not known whether admission to internal medicine is as effective as admission to a unit specialising in a specific organ, such as hepato-gastro-enterology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The Internal Medicine Unit arm

It includes all patients hospitalized in the Internal Medicine Unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.

Data collection

Intervention Type OTHER

Data collected: Socio-demographic, hospital, clinical, biological, and imaging data

The hepato-gastro-enterology Unit arm

It includes all patients hospitalized in the Gastroenterology unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.

Data collection

Intervention Type OTHER

Data collected: Socio-demographic, hospital, clinical, biological, and imaging data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data collection

Data collected: Socio-demographic, hospital, clinical, biological, and imaging data

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patient
* primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kyria REGALADE, resident

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Saint-Etienne

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kyria REGALADE, resident

Role: CONTACT

(0)782651553 ext. +33

Baptiste GRAMONT, MD

Role: CONTACT

(0)477829641 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kyria REGALADE, resident

Role: primary

(0)782651553 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRBN902024/CHUSTE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Registry of Pancreatic Disease
NCT03807687 RECRUITING
PERT in Acute Necrotizing Pancreatitis
NCT07211568 NOT_YET_RECRUITING PHASE3
SERum-bank for PANcreatic Cancer
NCT04374175 RECRUITING